In vitro activity of antimicrobial agents against the Mycobacterium avium complex inside macrophages from HIV1-infected individuals: the link to clinical response to treatment?
Yajko
D M
DM
Department of Laboratory Medicine, University of California, San Francisco General Hospital 94110.
D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000382:microbiology; D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D001992:Bronchoalveolar Lavage Fluid / Q000150:complications / Q000382:microbiology; D017291:Clarithromycin / Q000494:pharmacology; D004359:Drug Therapy, Combination / Q000494:pharmacology; D004917:Erythromycin / Q000494:pharmacology; D024841:Fluoroquinolones; D006801:Humans; D008264:Macrophages / Q000187:drug effects* / Q000382:microbiology; D015269:Mycobacterium avium Complex / Q000187:drug effects* / Q000302:isolation & purification; D015270:Mycobacterium avium-intracellulare Infection / Q000150:complications / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D004917:Erythromycin; D017291:Clarithromycin